EU External Trade - Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale, Other, containing antimalarial active principles described in Subheading Note 2|to this Chapter

Extra-EU sourcing of Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale, Other, containing antimalarial active principles described in Subheading Note 2|to this Chapter is highly concentrated. 🇳🇴 Norway captures 71.0% of imports (€214K), followed by 🇨🇭 Switzerland (23.2%). With an HHI of 5593, this Concentrated market exposes the EU to supply dependency risks.

European exports of Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale, Other, containing antimalarial active principles described in Subheading Note 2|to this Chapter are concentrated on a few markets. 🇨🇭 Switzerland accounts for 82.6% (€4.4M), ahead of 🇨🇦 Canada (10.4%). The top three destinations are 🇨🇭 Switzerland, 🇨🇦 Canada, 🇸🇻 El Salvador.

Within the EU, 🇫🇷 France concentrates 71.4% of Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale, Other, containing antimalarial active principles described in Subheading Note 2|to this Chapter imports, well ahead of 🇮🇹 Italy (22.0%). The top importing member states are 🇫🇷 France, 🇮🇹 Italy, 🇭🇺 Hungary.

In 2025, trade flows diverged: imports were falling sharply (-74.5%) while exports were surging (172.3%), signalling a structural market shift.